Calculator Fractional Excretion of Sodium (FENa)
Use this clinical tool to estimate FENa from urine and serum sodium plus creatinine values. This supports AKI pattern recognition, especially when interpreted with exam, urine microscopy, and medication context.
Expert Guide: How to Use a Calculator for Fractional Excretion of Sodium
Fractional excretion of sodium, usually written as FENa, is a practical bedside calculation that estimates what fraction of filtered sodium is excreted in the urine. In acute kidney injury (AKI), this can help differentiate patterns of kidney dysfunction, especially when clinicians are trying to separate reduced renal perfusion states from established tubular injury. A calculator makes the math easy, but the clinical interpretation still requires careful context.
The core equation is: FENa (%) = (Urine Na × Serum Cr) / (Serum Na × Urine Cr) × 100. Sodium is typically entered as mmol/L or mEq/L, and creatinine may be entered as mg/dL or umol/L. The key principle is unit consistency. If creatinine units differ between serum and urine values, convert one before computing. The calculator above does this automatically.
Why FENa Matters in AKI Evaluation
In states of decreased effective circulating volume, kidneys attempt to preserve intravascular volume by reabsorbing sodium avidly. That often produces a low urinary sodium concentration and low FENa. In contrast, when tubular function is impaired, as in acute tubular injury, sodium reabsorption is less efficient and FENa tends to rise. This physiology makes FENa an appealing first pass marker during early AKI assessment.
- FENa less than 1% often suggests sodium retention physiology, commonly seen in volume responsive states.
- FENa between 1% and 2% is a gray zone that needs stronger clinical correlation.
- FENa above 2% is more compatible with intrinsic tubular injury in the right context.
- FENa above 3% can strongly support impaired tubular sodium reabsorption, but never in isolation.
Important caveat: FENa is less reliable when patients recently received diuretics, in chronic kidney disease, in sepsis associated AKI, and in non oliguric states. Use it as a component of a broader diagnostic bundle rather than as a stand alone verdict.
Step by Step: Using the Calculator Correctly
- Enter urine sodium and serum sodium from labs drawn close together in time.
- Enter urine and serum creatinine from the same sampling window whenever possible.
- Select creatinine units for each input. The calculator converts values internally.
- Add context, such as diuretic exposure and urine output pattern.
- Click Calculate and review both numeric result and interpretation.
- Integrate with urinalysis, microscopy, hemodynamics, medications, and trend data.
Worked Clinical Example
Suppose a patient has urine sodium 18 mEq/L, serum sodium 138 mEq/L, urine creatinine 120 mg/dL, and serum creatinine 2.1 mg/dL. FENa = (18 × 2.1) / (138 × 120) × 100. Numerator = 37.8. Denominator = 16,560. Fraction = 0.00228. Multiply by 100 gives 0.23%. This result supports sodium avidity. If exam and hemodynamics suggest reduced perfusion, the pattern can be compatible with a volume responsive process.
Comparison Table: Diagnostic Performance Across Clinical Contexts
| Clinical setting | Test and cutoff | Sensitivity | Specificity | Interpretation notes |
|---|---|---|---|---|
| Oliguric AKI without CKD and without diuretics (systematic review data) | FENa less than 1% for prerenal pattern | About 95% | About 91% | Best performance scenario for FENa use. |
| Broader AKI cohorts including CKD or diuretic exposure | FENa less than 1% for prerenal pattern | About 83% | About 66% | Significant drop in diagnostic accuracy. |
| Diuretic exposed patients in selected cohorts | FEUrea less than 35% for prerenal pattern | Roughly 70% to 80% | Roughly 70% to 85% | FEUrea can be considered when FENa is confounded by natriuresis. |
Performance metrics vary by study design, AKI definition, timing of samples, and population characteristics. Treat these numbers as context anchors rather than absolute truths for every bedside decision.
Classic Historical Data and Why It Still Gets Cited
The classic 1970s studies that introduced FENa demonstrated clear separation between volume responsive states and acute tubular necrosis in carefully selected populations. In those cohorts, many prerenal cases clustered below 1%, while many tubular injury cases were above 3%. This early signal is why FENa became embedded in nephrology teaching. However, modern inpatient populations are more complex, with more comorbidity, mixed etiologies, and medication effects, so contemporary interpretation must be more nuanced.
| Historical pattern summary | Typical FENa finding | Physiology behind result | Practical bedside implication |
|---|---|---|---|
| Volume responsive or reduced effective circulating volume states | Often less than 1% | Kidney conserves sodium through intact tubular reabsorption | Supports perfusion focused management when clinical picture matches |
| Established tubular injury | Often above 2%, frequently above 3% | Tubular sodium handling is impaired | Suggests intrinsic injury pathway, triggers broader etiologic workup |
| Mixed causes or treatment confounders | Intermediate or paradoxical values | Competing physiologic signals | Use integrated approach with urine microscopy and serial data |
Common Pitfalls That Distort FENa
- Recent loop or thiazide diuretics: sodium excretion rises independent of true tubular reserve.
- Chronic kidney disease: baseline tubular handling changes can blur thresholds.
- Contrast exposure, pigment injury, or sepsis: mixed pathophysiology can create misleading values.
- Delayed or mismatched sampling: non synchronous blood and urine labs weaken interpretation.
- Non oliguric AKI: performance can be lower than in classic oliguric cohorts.
How to Integrate FENa with Other Data
Strong AKI evaluation combines multiple streams. Bedside exam, blood pressure trend, jugular venous findings, mucous membrane status, and point of care ultrasound often provide immediate perfusion clues. Urinalysis and microscopy can show muddy brown granular casts, hyaline casts, hematuria, or protein patterns that direct differential diagnosis. Medication review can uncover nephrotoxins, renin angiotensin blockers, NSAIDs, diuretics, and antibiotics that alter both kidney function and lab interpretation.
Many teams pair FENa with FEUrea, especially in diuretic exposed patients. Others prioritize trend based interpretation: if creatinine is rising and urine sediment evolves toward tubular injury, an isolated low FENa should not overrule the broader pattern. Conversely, in a patient with hypotension and concentrated urine, a low FENa can reinforce a perfusion hypothesis.
Frequently Asked Questions
Is 1% a hard diagnostic boundary?
No. It is a practical threshold, not a biological wall. Use confidence ranges and context.
Can I use mmol/L and mEq/L for sodium?
Yes, for monovalent sodium these are numerically equivalent in routine practice.
If urine sodium is low, do I still need FENa?
Often yes. FENa incorporates creatinine correction and can be more informative than urine sodium alone.
Should FENa guide therapy by itself?
No. It should support, not replace, clinical judgment and full AKI workup.
Authoritative References and Further Reading
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Acute Kidney Injury
- NIH NCBI Bookshelf: Fractional Excretion of Sodium clinical review
- MedlinePlus (U.S. National Library of Medicine): Sodium testing overview
Bottom Line for Clinical Practice
A fractional excretion of sodium calculator is fast, useful, and physiologically grounded. It performs best in carefully selected oliguric AKI scenarios without major confounders. In complex modern inpatient care, treat FENa as one calibrated signal among many. If you combine it with clinical exam, urine microscopy, medication review, and serial trends, it can meaningfully improve diagnostic precision and bedside decision quality.